Letters by company
Flex LTD.
11 letters discussing FLEX. Everything written about it on this site is on its ticker page.
- Artisan Partners Artisan Small Cap Fund Quarterly Commentary Artisan Small Cap Fund trimmed Twist Bioscience, MACOM Technology Solutions and Modine after appreciation, while reducing Installed Building Products and Ascendis Pharma as their profit cycles faced setbacks. The team initiated Virtu Financial, Murphy USA and USA Rare Earth, and shifted software underweight as AI alters competitive dynamics and monetization prospects. Q2 2026 ASND $15BCIGI $4.4BFLEX $34B
- Artisan Partners Artisan Small Cap Fund Quarterly Commentary Artisan Small Cap Fund added to Modine Manufacturing and Twist Bioscience as data-center cooling, synthetic-biology demand and company execution strengthened conviction. The portfolio initiated Onto Innovation, Baldwin Group and Freshpet, while exiting Penumbra, JBT Marel and Parsons and reducing several positions on valuation, mandate size or weakening profit-cycle visibility. Q1 2026 BWIN $4.5BCOMP $6.8BFLEX $34B
- Lyrical Asset Management 2025 Global Review Letter Lyrical Global credits bottom-up stock selection and portfolio earnings growth for keeping pace with a market led by mega-cap technology and European banks it avoided. It retained AI beneficiaries NRG Energy, Johnson Controls and Flex, sold United Rentals after it reached intrinsic value, and argues AerCap offers a more resilient financial-services model than banks. 2025 AER $23BFLEX $34BJCI $88B
- Sound Shore Management December 31, 2025 Sound Shore credited a broad set of value holdings, including Regeneron, TEVA, General Motors, Southwest Airlines and Citigroup, for offsetting the market’s concentration in technology. The fund added to its case for FLEX and Huntington Ingalls while selling PayPal and PVH after consumer and tariff concerns weakened their prospects. 2025 FLEX $34BHII $11BPVH $3.8B
- Artisan Partners Quarterly Commentary: Artisan Small Cap Fund Artisan Small Cap Fund added to MACOM after temporary profit-cycle pressure, then trimmed it as valuation rose, while exiting Insmed, Integer Holdings and SharkNinja. The fund initiated nLIGHT, Guardant Health and Cellebrite, and increased Bruker, Hexcel and Penumbra on product-cycle, aerospace and medical-device adoption catalysts. Q4 2025 BRKR $8.6BCLBT $2.8BCOCO $3.4B
- Sound Shore Management December 31, 2024 Sound Shore argues that overlooked companies undergoing operational or strategic transformation offer value beyond concentrated passive indices. The fund cites AI-related exposure through Vistra, Baker Hughes and Oracle, builds cases for Flex and Teva, and sold Boeing after new manufacturing issues delayed its restructuring. fourth quarter of 2024 BA $147BFLEX $34BTEVA $48B
- Royce Investment Partners Royce Capital Fund–Small-Cap Portfolio Manager Commentary Royce Capital Fund–Small-Cap added to Maximus and IBEX after share-price weakness, while exiting Molina Healthcare amid pressure on its Medicaid earnings. The portfolio favors selected AI-infrastructure beneficiaries but warns that indiscriminate AI spending, geopolitical disruption and persistent inflation could unsettle small-cap markets. first six months of 2026 BLBD $1.9BIBEX $606MMMS $3B
- Lyrical Asset Management 2025 U.S. Value Review Letter Lyrical Asset Management argues that capitalization-weighted S&P 500 gains have been driven by valuation expansion rather than superior earnings growth, leaving its value portfolio at a wide discount despite faster historical EPS growth. AI-linked holdings NRG Energy, Johnson Controls and Flex helped offset multiple compression elsewhere, while United Rentals was sold after reaching fair value. 2025 —
- Lyrical Asset Management 2025 Global Impact Value Equity Strategy (GIVES) Review GIVES attributed its year to earnings growth across undervalued holdings, while avoiding mega-cap growth stocks and crowded sustainability names. The strategy pressed Wesco to measure and disclose Scope 3 emissions, and expects valuation gaps between value stocks, smaller companies and mega-caps to narrow over time. 2025 6091 $76MAPTV $9.5B
- Sound Shore Management June 30, 2025 Sound Shore added to Teva Pharmaceutical and Hologic during healthcare-policy uncertainty, citing Teva’s pipeline and Hologic’s valuation and strategic appeal. The portfolio benefited from FLEX’s data-center exposure, retained AES despite renewable-tax-credit concerns, and views Disney’s streaming repositioning and ESPN launch as drivers of further value. second quarter 2025 DIS $192B
- Sound Shore Management March 31, 2024 Sound Shore Fund attributed its first-quarter advance to adaptable businesses including Vistra, Constellation Energy, Teva Pharmaceutical and Acuity Brands, while emphasizing valuation alongside resilient business models. The fund added Constellation on expectations for improving earnings and sold Boeing after new manufacturing problems threatened to delay its restructuring. first quarter 2024 AYI $9BBA $147BCEG $105B
